1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Cancer of Endometrium in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (42.86) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, W; Lash, GE; Liu, Y; Qian, Y; Shi, K; Su, Y; Wang, Q; Xuan, X | 1 |
Baldi, E; Bonaccorsi, L; Cioppi, F; Granchi, S; Luconi, M; Maggi, M; Muratori, M; Peri, A | 1 |
Choi, IH; Choi, JH; Im, SY; Jung, B; Ko, HM; Lee, HK; Lee, HS; Park, SJ; Seo, KH | 1 |
Baldi, E; Bonaccorsi, L; Carloni, V; Finetti, G; Forti, G; Laffi, G; Maggi, M; Muratori, M; Serio, M | 1 |
Kawano, Y; Matsui, N; Miyakawa, I; Narahara, H; Nasu, K; Tanaka, Y | 1 |
Fukunaga, K; Miyamoto, E; Miyazaki, K; Munir, I; Okamura, H | 1 |
Baldi, E; Bonaccorsi, L; Cioppi, F; Forti, G; Granchi, S; Luconi, M; Maggi, M; Miele, L; Mini, E; Muratori, M; Peri, A; Pesciullesi, A; Serio, M | 1 |
1 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Cancer of Endometrium
Article | Year |
---|---|
The effects of an autocrine loop mediated by platelet-activating factor (PAF) in HEC-1A cells are reverted by uteroglobin.
Topics: Adenocarcinoma; Animals; Autocrine Communication; Cell Division; Cell Line, Tumor; Endometrial Neoplasms; Female; Humans; Mitogen-Activated Protein Kinases; Phospholipases A; Platelet Activating Factor; Protein Kinase C; Uteroglobin | 2003 |
6 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Cancer of Endometrium
Article | Year |
---|---|
Identification and functional analyses of differentially expressed metabolites in early stage endometrial carcinoma.
Topics: Apoptosis; Autophagy; Cell Line, Tumor; Cell Movement; Cell Proliferation; Endometrial Neoplasms; Female; Humans; Indoles; Metabolome; Metabolomics; Middle Aged; Neoplasm Invasiveness; Phenylalanine; Platelet Activating Factor; Tryptophan; Tumor Necrosis Factor-alpha | 2018 |
Estrogen enhances angiogenesis through a pathway involving platelet-activating factor-mediated nuclear factor-kappaB activation.
Topics: Adenocarcinoma; Animals; Endometrial Neoplasms; Estradiol Congeners; Female; Fibroblast Growth Factor 2; Interleukin-1; Interleukin-8; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; NF-kappa B; Phospholipases A; Phospholipases A2; Platelet Activating Factor; RNA, Messenger; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A | 2004 |
Platelet-activating factor mediates an autocrine proliferative loop in the endometrial adenocarcinoma cell line HEC-1A.
Topics: Acetyl-CoA C-Acetyltransferase; Adenocarcinoma; Binding, Competitive; Calcium; Cell Count; Cell Cycle; Cell Division; Chromatography, Gas; Endometrial Neoplasms; Female; Furans; Humans; Platelet Activating Factor; Proto-Oncogene Proteins c-fos; RNA; RNA, Messenger; Tumor Cells, Cultured | 1994 |
Platelet-activating factor stimulates cytokine production by human endometrial stromal cells.
Topics: Adult; Cell Line; Chemokine CCL3; Chemokine CCL4; Cytokines; Endometrial Neoplasms; Endometrium; Female; Humans; Interleukin-6; Interleukin-8; Macrophage Colony-Stimulating Factor; Macrophage Inflammatory Proteins; Phospholipid Ethers; Platelet Activating Factor; Sarcoma; Stromal Cells; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1999 |
Mitogen-activated protein kinase activation and regulation of cyclooxygenase 2 expression by platelet-activating factor and hCG in human endometrial adenocarcinoma cell line HEC-1B.
Topics: Adenocarcinoma; Androstadienes; Antineoplastic Agents, Hormonal; Chorionic Gonadotropin; Cyclic AMP; Cyclooxygenase 2; Endometrial Neoplasms; Enzyme Activation; Enzyme Inhibitors; Estradiol; Female; Flavonoids; Humans; Isoenzymes; Isoquinolines; Medroxyprogesterone Acetate; Membrane Proteins; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Mitogens; Platelet Activating Factor; Prostaglandin-Endoperoxide Synthases; Protein Kinase Inhibitors; Signal Transduction; Sulfonamides; Thionucleotides; Tumor Cells, Cultured; Wortmannin | 1999 |
Uteroglobin reverts the transformed phenotype in the endometrial adenocarcinoma cell line HEC-1A by disrupting the metabolic pathways generating platelet-activating factor.
Topics: Acetyltransferases; Adenocarcinoma; Arachidonic Acid; Cell Cycle; Cell Division; Cell Membrane; Cell Transformation, Neoplastic; Endometrial Neoplasms; Female; Humans; Kinetics; Phospholipases A; Platelet Activating Factor; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; Transcription, Genetic; Transfection; Tumor Cells, Cultured; Uteroglobin | 2000 |